An observational study in Diabetes Mellitus and Obesity, sponsored by Medical University of Vienna. Completed at 8 sites in 8 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Medical University of Vienna · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Diabetes Mellitus by Medical University of Vienna — 1 open to participants now, 1 under way, none of them phase 3. Diabetes Mellitus · Medical University of Vienna.
Among the 13 studies in Diabetes Mellitus by Medical University of Vienna, this one is the only one that started in 2024, is one of 3 observational ones, and was the 12th registered.
8,295 studies on the registry are indexed under Diabetes Mellitus; 1,071 are open to participants now.
Browse Diabetes Mellitus studies →1 of the 13 studies in Diabetes Mellitus by Medical University of Vienna is open now, in 1 country. Recruiting first, the newest first:
Medical University of Vienna · Sites in Austria
Ages 18+
By country, each count listing its studies:
Of the 649 Diabetes Mellitus studies recruiting now, 358 (55%) set no upper age limit and 194 (30%) stop at 75 or younger; 89 take children under 18; 181 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 1 · Phase 4 2
First in 2002; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 207 is below the median of 246 across 1,935 observational studies indexed under Diabetes Mellitus.
Median enrollment 18 across the 10 interventional studies, 51 across the 3 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Medical University of Vienna is the lead sponsor of 1,111 studies on the registry; 186 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Diabetes Mellitus by Medical University of Vienna, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.
However, the pharmacological treatment of diabesity has made significant progress in recent years.
The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:
Adults (age ≥ 18 years) with diabetes who are admitted to an internal medicine ward of a participating medical centre at the time of the study
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.
Number of point-of-care glucose values
Mean number of point-of-care glucose measurements during hospitalization
Time frame: 3 days
Severe hypoglycaemia
Severe hypoglycaemia during admission (glucose \<40mg/dL)
Time frame: From day of admission to the day of data collection, i.e., November 14, 2024
Diabetes treatment during hospitalization
Diabetes treatment used during the time of hospitalization
Time frame: From day of admission to the day of data collection, i.e., November 14, 2024
Insulin regimen during hospitalization
Insulin regimen used during the time of hospitalization (e.g., correction, basal, prandial bolus)
Time frame: From day of admission to the day of data collection, i.e., November 14, 2024
Plan to share: No — Patient data will only be shared in aggregated form.
No publications or documents are linked to this record.
Ran from Nov 2024 to primary completion in Mar 2025, 4 months.
Completion moved once since we started tracking on Sep 25, 2026: May 2025 → Sep 2025, on Oct 7, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna →